Otsuka Wins FDA Approval for World’s First Digital Medicine (News)
[2017.11.15] Read in: 日本語 | العربية | Русский |

Tokyo, Nov. 14 (Jiji Press)—Otsuka Pharmaceutical Co. said Tuesday it has obtained approval from the US Food and Drug Administration to manufacture and sell its oral aripiprazole tablets embedded with a miniscule sensor, the world’s first digital medicine system.

The system is designed to ensure that patients with severe mental illnesses take drugs every day. If such patients forget to take their medications, they cannot lead everyday lives, increasing the burden on family members and caregivers.

The Abilify MyCite system, jointly developed by the Japanese company and US medical equipment company Proteus Digital Health Inc., includes tablets with a 3-millimeter ingestible sensor and a wearable patch signal detector.

Data will be transmitted when the tablet dissolves in a patient’s stomach and the sensor makes contact with stomach fluid. The detector will then receive the information, and the level of drug ingestion can be tracked.

The detector can also provide information including the patient’s temperature and heart rate.

[Copyright The Jiji Press, Ltd.]

  • [2017.11.15]
Related articles
Other columns

Video highlights

New series

バナーエリア2
  • From our columnists
  • In the news